Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, August 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs: 2 blogs
twitter: 30 X users

patent: 1 patent

Readers on

mendeley: 98 Mendeley

So far, Altmetric has seen 32 X posts from 30 X users, with an upper bound of 72,439 followers.

Breast cancer Wang et al. (2016) — cytostatic autophagy via PAK1/Akt axis; suppresses xenograft growth. Cancer Research. https://t.co/irJGP2bR3S Draganov et al. (2021) — converts "cold" tumors "hot," immunogenic cell death, synergy with anti-PD-1. https:/…

@davideyoungmd @Ivermectinkart Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer https://t.co/yI9eLtWiL8

@DrNeilStone https://t.co/WqozNL5PK1

Ivermectin has been shown to be able to kill cancer cells of many types, such as Breast Cancer: 1. https://t.co/PieAxiooB5 2. https://t.co/T63NwVy9wK 3.https://t.co/UTGUkNXul2 Ovarian Cancer 1. https://t.co/T63NwVy9wK …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 28 additional X posts.